Citius Oncology, Inc. (CTOR)
1.22
+0.04
(+3.39%)
USD |
NASDAQ |
Feb 13, 16:00
1.19
-0.03
(-2.46%)
After-Hours: 20:00
Citius Oncology EPS Diluted (Quarterly) : -0.0633 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -0.3824 |
| Amgen, Inc. | 2.455 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Soligenix, Inc. | -0.5846 |
| Tonix Pharmaceuticals Holding Corp. | -3.587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.534M |
| Revenue (Quarterly) | 3.944M |
| Total Expenses (Quarterly) | 9.478M |
| Enterprise Value | 104.20M |
| Gross Profit Margin (Quarterly) | 79.99% |
| Profit Margin (Quarterly) | -140.3% |
| Earnings Yield | -25.25% |
| Normalized Earnings Yield | -25.26 |